|
⚲
|
| Keyboard |
| Pykett Mark Jerome
✚
|
|
|---|---|
| CIK # | 0001278271 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001278271] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pykett Mark Jerome | |
| Navidea Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2014-06-01 | Grant | 20,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2014-05-09 | Buy | 10,000 | $1.34 | 13,400 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2014-03-10 | Sell | 120,000 | $1.96 | 235,200 |
|
Navidea Biopharmaceuticals Inc NAVB
Stock Option (Right to Buy) · derivative
|
2014-01-28 | Grant | 258,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2013-11-08 | Buy | 10,900 | $1.35 | 14,715 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2013-03-15 | Buy | 1,850 | $2.70 | 4,995 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2013-03-13 | Grant | 125,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2013-03-13 | Tax withheld | 43,236 | $3.16 | 136,626 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2013-02-17 | Disposed to issuer | 35,000 | $3.08 | 107,800 |
|
Navidea Biopharmaceuticals Inc NAVB
Stock Option (Right to Buy) · derivative
|
2013-02-15 | Grant | 304,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2012-09-11 | Buy | 4,000 | $2.64 | 10,560 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2012-02-17 | Grant | 300,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Stock Option (Right to Buy) · derivative
|
2012-02-17 | Grant | 250,000 | $0.00 |